Literature DB >> 21697243

Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula.

Lu Kang1, Satsuki Yamada, Melissa C Hernandez, Anthony J Croatt, Joseph P Grande, Julio P Juncos, Gregory M Vercellotti, Robert P Hebbel, Zvonimir S Katusic, Andre Terzic, Karl A Nath.   

Abstract

The study of hemodynamic alterations following the creation of an arteriovenous fistula (AVF) is relevant to vascular adaptive responses and hemodialysis access dysfunction. This study examined such alterations in a murine AVF created by anastomosing the carotid artery to the jugular vein. AVF blood flow was markedly increased due to reduced AVF vascular resistance. Despite such markedly increased basal blood flow, AVF blood flow further increased in response to acetylcholine. This AVF model exhibited increased cardiac output and decreased systemic vascular resistance; the kidney, in contrast, exhibited decreased blood flow and increased vascular resistance. Augmentation in AVF blood flow was attended by increased arterial heme oxygenase-1 (HO-1) mRNA and protein expression, the latter localized to smooth muscle cells of the AVF artery; AVF blood flow was substantially reduced in HO-1(-/-) mice compared with HO-1(+/+) mice. Finally, in a murine model of a representative disease known to exhibit impaired hemodynamic responses (sickle cell disease), the creation of an AVF was attended by decreased AVF flow and impaired AVF function. We conclude that this AVF model exhibits markedly increased AVF blood flow, a vasodilatory reserve capacity, increased cardiac output, decreased renal blood flow, and a dependency on intact hemodynamic responses, in general, and HO-1 expression, in particular, in achieving and maintaining AVF blood flow. We suggest that these findings support the utility of this model in investigating the basis for and the consequences of hemodynamic stress, including shear stress, and the pathobiology of hemodialysis AVF dysfunction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697243      PMCID: PMC3191805          DOI: 10.1152/ajprenal.00311.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  38 in total

1.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 2.  Why don't fistulas mature?

Authors:  B S Dixon
Journal:  Kidney Int       Date:  2006-08-02       Impact factor: 10.612

3.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.

Authors:  C Iadecola; F Zhang; K Niwa; C Eckman; S K Turner; E Fischer; S Younkin; D R Borchelt; K K Hsiao; G A Carlson
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

4.  Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.

Authors:  Satsuki Yamada; Garvan C Kane; Atta Behfar; Xiao-Ke Liu; Roy B Dyer; Randolph S Faustino; Takashi Miki; Susumu Seino; Andre Terzic
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

5.  Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease.

Authors:  K A Nath; V Shah; J J Haggard; A J Croatt; L A Smith; R P Hebbel; Z S Katusic
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-12       Impact factor: 3.619

6.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

7.  A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.

Authors:  Robert P Hebbel; Greg Vercellotti; Karl A Nath
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2009-12

8.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

Review 9.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

10.  Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice.

Authors:  Michal J Tracz; Julio P Juncos; Joseph P Grande; Anthony J Croatt; Allan W Ackerman; Govindarajan Rajagopalan; Keith L Knutson; Andrew D Badley; Matthew D Griffin; Jawed Alam; Karl A Nath
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

View more
  8 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo.

Authors:  Lu Kang; Matthew L Hillestad; Joseph P Grande; Anthony J Croatt; Michael A Barry; Gianrico Farrugia; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-27       Impact factor: 4.733

3.  A Novel Murine Model of Arteriovenous Fistula Failure: The Surgical Procedure in Detail.

Authors:  Chun Yu Wong; Margreet R de Vries; Yang Wang; Joost R van der Vorst; Alexander L Vahrmeijer; Anton-Jan van Zonneveld; Jaap F Hamming; Prabir Roy-Chaudhury; Ton J Rabelink; Paul H A Quax; Joris I Rotmans
Journal:  J Vis Exp       Date:  2016-02-03       Impact factor: 1.355

4.  Functioning of an arteriovenous fistula requires heme oxygenase-2.

Authors:  Lu Kang; Joseph P Grande; Gianrico Farrugia; Anthony J Croatt; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-15

Review 5.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

6.  A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.

Authors:  Lu Kang; Joseph P Grande; Matthew L Hillestad; Anthony J Croatt; Michael A Barry; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16

7.  Effect of local anti-vascular endothelial growth factor therapy to prevent the formation of stenosis in outflow vein in arteriovenous fistula.

Authors:  Xin Huang; Jibin Guan; Zitong Sheng; Menghua Wang; Tianhua Xu; Guangying Guo; Pengzhi Wan; Binyao Tian; Junlei Zhou; Aoran Huang; Junfeng Hao; Li Yao
Journal:  J Transl Int Med       Date:  2021-12-31

8.  Effects of Tongmai oral liquid in femoral ateriovenous fistula.

Authors:  Pei-Ling Su; Kun Bao; Han-Guo Peng; Wei Mao; Guan-Su Wang; Ni-Zhi Yang; Wen-Jia Geng; Yi-Qun Lin; Xi-Na Jie
Journal:  BMC Complement Altern Med       Date:  2015-09-07       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.